Establishment Labs reported a strong first quarter with worldwide sales reaching $38.5 million, a 26.8% increase year-over-year. The company is maintaining its 2022 revenue guidance of $155 million to $165 million.
Worldwide sales of $38.5 million, an increase of 26.8% year-over-year and a new quarterly record.
Gross profit for the first quarter was 64.8% of revenue.
Cash balance of $44.7 million as of March 31, 2022; entered into $225 million credit facility with Oaktree Capital on April 26, 2022.
Modular PMA submission for U.S. FDA approval progressing with second module submitted to the FDA
The company is maintaining its 2022 revenue guidance of $155 million to $165 million, which is an annual growth rate of 22% to 30%.
Analyze how earnings announcements historically affect stock price performance